Author

Romi Ghose

University of Houston - Cited by 1,383 - Cytochrome P450 - Drug Metabolism - Drug Toxicity

Biography

Dr.  Romi Ghose is currently working in Center for Acute Care Nephrology, Cincinnati Children’s Hospital and Medical Center, University of Cincinnati, USA. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters
R Ghose, O Omoluabi, A Gandhi, P Shah, K Strohacker, KC Carpenter, ...Life sciences 89 (1-2), 57-64, 2011201
129
2011
Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review
AL Myers, JD Kawedia, RE Champlin, MA Kramer, Y Nieto, R Ghose, ...Expert opinion on drug metabolism & toxicology 13 (9), 901-923, 2017201
87
2017
Drug disposition in pathophysiological conditions
A Gandhi, B Moorthy, R GhoseCurrent drug metabolism 13 (9), 1327-1344, 2012201
82
2012
Role of c-Jun N-terminal kinase (JNK) in regulating tumor necrosis factor-alpha (TNF-α) mediated increase of acetaminophen (APAP) and chlorpromazine (CPZ) toxicity in murine …
A Gandhi, T Guo, R GhoseThe Journal of toxicological sciences 35 (2), 163-173, 2010201
56
2010
Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: Implications for biologics–small molecule drug interactions
P Mallick, G Taneja, B Moorthy, R GhoseExpert opinion on drug metabolism & toxicology 13 (6), 605-616, 2017201
43
2017
Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters
P Shah, T Guo, DD Moore, R GhoseDrug Metabolism and Disposition 42 (1), 172-181, 2014201
37
2014
Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug …
R Ghose, T Guo, JG Vallejo, A GandhiDrug metabolism and disposition 39 (5), 874-881, 2011201
34
2011
CYP3A‐dependent drug metabolism is reduced in bacterial inflammation in mice
AS Gandhi, T Guo, P Shah, B Moorthy, DSL Chow, M Hu, R GhoseBritish journal of pharmacology 166 (7), 2176-2187, 2012201
27
2012
Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice
A Gandhi, T Guo, P Shah, B Moorthy, R GhoseToxicology and applied pharmacology 6 (3), 430-438, 2013201
26
2013
Neratinib in HER2-positive breast cancer patients
R Paranjpe, D Basatneh, G Tao, C De Angelis, S Noormohammed, ...Annals of Pharmacotherapy 53 (6), 612-6, 191
20
2019
Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity
G Tao, J Huang, B Moorthy, C Wang, M Hu, S Gao, R GhoseExpert opinion on drug metabolism & toxicology 16 (11), 1109-1124,
20
2020
Role of c-Jun-N-terminal kinase in pregnane X receptor-mediated induction of human cytochrome P4503A4 in vitro
G Taneja, C Chu, P Maturu, B Moorthy, R GhoseDrug Metabolism and Disposition 46 (4), 397-404, 2018201
16
2018
Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp)3a11 gene
G Taneja, S Maity, W Jiang, B Moorthy, C Coarfa, R GhoseScientific Reports 9 (1), 6663, 2019201
15
2019
Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice
P Mallick, P Shah, A Gandhi, R GhoseLife sciences 9, 2-8, 2015201
13
2015
Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt
R Sun, L Zhu, L Li, W Song, X Gong, X Qi, Y Wang, R Ghose, S Gao, M Hu, ...Toxicology and applied pharmacology 398, 115032, 2020202
13
2020
Impact of diet on irinotecan toxicity in mice
P Mallick, P Shah, MM Ittmann, M Trivedi, M Hu, S Gao, R GhoseChemico-Biological Interactions 291, 87-94, 2018201
11
2018
Role of adaptor protein Toll-like interleukin domain containing adaptor inducing interferon β in Toll-like receptor 3-and 4-mediated regulation of hepatic drug metabolizing …
P Shah, O Omoluabi, B Moorthy, R GhoseDrug Metabolism and Disposition 44 (1), 61-67, 2016201
11
2016
In vitro approaches to study regulation of hepatic cytochrome P450 (CYP) 3A expression by paclitaxel and rifampicin
R Ghose, P Mallick, G Taneja, C Chu, B MoorthyCancer Drug Resistance: Overviews and Methods, 55-68, 2016201
11
2016
Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro
P Mallick, S Basu, B Moorthy, R GhoseToxicology in Vitro 41, 75-82, 2017201
9
2017
Role of oxidative stress in the efficacy and toxicity of herbal supplements
G Tao, F Dagher, A Moballegh, R GhoseCurrent Opinion in Toxicology 20, 36-40, 2020202
7
2020

Referred From: https://scholar.google.com/citations?hl=en&user=UQTsU98AAAAJ

Cited by
Citations 1383
h-index 19
i10-index 28
Recommended Journals
Open Access Journals